COMMUNIQUÉS West-GlobeNewswire

Sana Biotechnology to Present at September 2024 Investor Conferences
29/08/2024
SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its [...]
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
29/08/2024
Strong balance sheet with successful completion of upsized $179.0 million initial public offering Treatment initiated in the first patient in an investigator-initiated basket trial of AlloNK® exploring multiple [...]
Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024
29/08/2024
IRVINE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences
29/08/2024
SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29/08/2024
LEXINGTON, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, has entered into an employment agreement with a newly [...]
Cytokinetics to Participate in September Investor Conferences
29/08/2024
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Company is scheduled to participate in the following investor conferences in September: [...]
Radiance BioPharma sponsoring Investor Cruise Event 2024
29/08/2024
BOSTON, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Radiance Biopharma Inc., a biopharmaceutical company developing next generation Antibody Drug Conjugates and Bispecific Antibody Drug Conjugates announced that Robert K. Brooks [...]
EssilorLuxottica: successful Euro 2 billion bond issuance at 2.99%
29/08/2024
NOT TO BE RELEASED, PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR [...]
EssilorLuxottica: Succès du placement d'une émission obligataire de 2 milliards d'euros à 2,99 %
29/08/2024
NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ETATS-UNIS D’AMÉRIQUE, AU CANADA, EN AUSTRALIE, AU JAPON, EN AFRIQUE DU SUD OU DANS TOUTE AUTRE JURIDICTION DANS LAQUELLE IL SERAIT ILLÉGAL DE LE [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2024
29/08/2024
Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2024 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2024
29/08/2024
Nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2024 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) [...]
RAMSAY SANTE : Provisional annual results at the end of June 2024
29/08/2024
PRESS RELEASE Paris, 29 th August 2024 Provisional annual results at the end of June 2024 As a mission-driven company, Ramsay Santé, thanks to its employees and medical community, is committed to expanding its [...]
RAMSAY SANTE : résultats annuels provisoires à fin juin 2024
29/08/2024
COMMUNIQUÉ DE PRESSE Paris, le 29 août 2024 Résultats annuels provisoires à fin juin 2024 Entreprise à mission, Ramsay Santé, grâce à ses collaborateurs et sa communauté médicale, s’engage à poursuivre et accélérer dans [...]
iTeos annonce sa participation aux prochaines journées Investisseurs
29/08/2024
WATERTOWN, Massachusetts et GOSSELIES, Belgique, 29 août 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq : ITOS) (« iTeos »), une société biopharmaceutique au stade clinique, pionnière dans la découverte et le [...]
Major shareholder announcement
29/08/2024
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and [...]
Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024
29/08/2024
CAMBRIDGE, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President [...]
Anaptys Announces Participation in September Investor Conferences
29/08/2024
SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president [...]
Biomerica Reports Fiscal 2024 Year End Results
29/08/2024
Total Revenue Increases 1% Year-Over-Year – Core Revenue Excluding COVID Tests Climbs 5%, Reflecting Stronger Growth Significant Cost Savings Plan Implemented After Year End – Expected to Deliver Expense Reductions of $ [...]
Scilex Holding Company Announces FDA Final Approval to Precision Dosing for GLOPERBA® Label
29/08/2024
FDA Final Approval to Precision Dosing for GLOPERBA ® Label. We believe GLOPERBA ® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in [...]

Pages